Antibiotics, Antimicrobials & Resistance

Dr. Mark T. Hamann serves as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery, Biomedical Sciences and Public Health at the MUSC College of Pharmacy. He also holds Adjunct appointments with The University of Maryland’s Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine. Dr. Hamann began his career in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota and then completed a Ph.D. degree in Organic Chemistry at the University of Hawaii, under the guidance of the late Professor Paul J. Scheuer. During his graduate studies he discovered the lead anticancer agent, kahalalide F which entered clinical trials with the leadership of the biotech company PharmaMar. During his research career, Dr. Hamann has published over 200 scientific papers, reviews, book chapters and guided over 100 graduate students/postdoctoral fellows and visiting scholars. Dr. Hamann currently serves as an Associate Editor for Biochimica et Biophysica Acta, General Subjects. His group is actively involved in the isolation, structure determination and optimization through synthesis of natural products and toxins with a focus on plant and invertebrate microbiomes. His group is currently working on the preclinical development of a small pipeline of natural products with activity against cancer, emerging infectious diseases and neuropsychiatric disorders

Drug Discovery, Biomedical Sciences and Public Health.

Dr. Decho is Professor and Director of the Microbial Interactions Laboratory at the University of South Carolina Arnold School of Public Health. He also serves as Associate Dean for Research. Dr. Decho primary research interests center on attached forms of bacteria, called 'Biofilms', and the use of nanotechnology for combatting biofilms. The biofilm allows bacteria to act as coordinated groups rather than as individual cells, and are a center for natural antibiotic production. Biofilms contribute central roles in infection processes. The Decho lab is examining: (1) bacterial cell-cell communication (quorum sensing) and the use of nanoparticles to control QS; 2) searching natural environments for novel antibiotics to thwart biofilms, and 3) determining how nanoparticles can be used as antibiotic-delivery vehicles.

Alan Decho research interests center on attached forms of bacteria, called 'Biofillms'. The biofilm allows bacteria to act as a coordinated group rather than as individual cells. They form microscopic (invisible) coatings that are important in health, disease and environmental processes. In health, biofilms commonly occur in/on human body in many areas. They are important to proper health, but also play central roles in infection. They are also the predominant form of microbial life in natural environments. Dr. Decho currently teaches a graduate-undergraduate course on 'Biofilms in the Environment, Health and Disease.

John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981. He spent additional time studying at the University of Nottingham and the National Institute of Medical Research at Mill Hill, outside of London. He served in various capacities in the biomedical research fields until 2000 when he was founder of FiberCell Systems Inc. a company specializing in the research and supply of hollow fiber bioreactors. He has over 10 publications in the field and three patents relating to hollow fiber systems and is considered a world expert in the field.

Cell culture technology, stem cells, numismatics, oenophilia, cerevisaphilia, rock art posters, gratefuldeadophilia.

Dr. Nassiri is a former Associate Dean of Global Health and Director of Institute of International Health at Michigan State University. He is currently Professor of Clinical Pharmacology and Family Medicine/Community Health. He is an expert on Global Health issues, Tropical Diseases and Infectious Diseases including HIV/AIDS and TB. His current research is focused on antibiotic resistance, public health aspects of tropical disease and infectious diseases, and gaps in HIV/AIDS care delivery systems.

antibiotic resistance, public health aspects of tropical disease and infectious diseases, and gaps in HIV/AIDS care delivery systems.

Dr. A.C. Matin got his Ph.D from University of California in Microbiology (1969). He is serving as the Chair of MS senate task force on posdoctoral affairs (2009- present), Member of MS senate steering committee (2008-present) & Senator of Medical School senate (2006-present). He is a Fellow of the American Academy of Microbiology. He got 16 Honors and Awards which are Star Award in Environmental Protection Agency (1991-1997), Review Committee Member in Accreditation Board for Engineering and Technology (1992) and Foundation for Microbiology Lecturer in American Society for Microbiology (1991-1993). He has authored about 37 Publications that include review articles. His Community & International Work involved in Bacterial antibiotic resistance in space flight, Stanford University; NASA Ames and Nuclear waste remediation.

A. C. Matin is a Professor of Microbiology and Immunology at Stanford University in Stanford, California. He has made pioneering contributions to microbiology in a number of areas; these include his notable research into the ways in which bacteria like Escherichia coli adapt and survive periods of nutrient starvation. His studies have been important in combating infections and the remediation of wastes.

Dr. Mingtao Zeng is Associate Professor of the Center of Emphasis in Infectious Diseases, Texas. He B.S. Biology, Sichuan University, China. 1985. Dr. Mingtao Zeng received his Ph.D. in Biochemistry from Tel Aviv University in 1998. He/she was a post-doctoral fellow at the Department of Molecular & Cell BiologyUniversity of California, Berkeley, California, 1997-1998. Dr. Mingtao Zeng has over 39 peer reviewed publications and is funded by the NIH, VA, NSF and several foundations. Dr. Mingtao Zeng research interests include new-generation vaccines against human respiratory pathogens such as influenza viruses, Streptococcus pneumoniae, nontypeable Haemophilus influenzae (NTHi), and agents important for biodefense such as Bacillus anthracis, botulinum neurotoxins, and Francisella tularensis.

Developing next-generation vaccines against human respiratory pathogens such as influenza viruses, Streptococcus pneumoniae, nontypeable Haemophilus influenzae (NTHi) and agents important for biodefense, such as Bacillus anthracis, botulinum neurotoxins and Francisella tularensis. Our multi-component candidate vaccines are being formulated and delivered by noninvasive nasal, oral, or transcutaneous manners using recombinant viruses, bacteria, plasmid DNA and detoxified bacterial toxins as vaccine antigen delivery vehicles. The noninvasive and easy administration procedures are expected to eliminate pain associated with needle injection, to reduce the requirement for specially trained personnel and equipment, and to permit rapid vaccine deployment in a short time frame at a low cost.

will update soon.

Innate immune response of macrophages to Legionella pneumophila and Burkholderia cenocepacia, microbial pathogenesis, host-pathogen interaction, autophagy, NOD-like receptors, non-apoptotic functions of caspases and the inflammasome complex.

Dr. Izzeldin Abuelaish received his elementary, preparatory and secondary education in the refugee camp schools, followed by a scholarship to study medicine in Cairo, Egypt and a diploma in Obstetrics and Gynecology from the Institute of Obstetrics and Gynecology at the University of London, UK. From 1997-2002, Dr. Abuelaish completed his residency in at the Soroka University hospital in Beer Sheva, Israel followed by a subspecialty in Fetal medicine in Italy and Belgium, and a Master’s in Public Health (Health Policy and Management) from Harvard University. He is the first Palestinian doctor to receive an appointment in Medicine at an Israeli hospital.

Global Public Health,women's health.

Liam is a co-founder and Director at Tecrea Ltd. Liam is also Professor of Microbiology and Biotechnology at the Royal Veterinary College, University of London, and sits on several scientific advisory and strategy boards. Prior to these positions, Liam completed a PhD in Canada, postdoctoral training at the Department of Cell and Molecular Medicine within the Panum Institute in Copenhagen, and was an Assistant Professor at the Karolinska Institute in Stockholm. Liam’s research and development interests include nanomedicine, antimicrobials, drug mechanisms and cellular delivery technologies.

Microbiology and Biotechnology.

Chit Laa Poh completed her PhD from Monash University, Australia in 1980 and returned to Malaysia and Singapore to pursue her academic career. Initially trained as an environmental bacteriologist, she started to focus on Medical Virology research since 1999 and worked on the development of rapid molecular diagnostics, novel antivirals and vaccines against Enterovirus 71 which can cause serious hand, foot and mouth disease (HFMD). She has achieved a Google H-index of 33. She is on the editorial board of Journal of Bioscience and Bioengineering (Elsevier) and Austin Journal of Tropical Medicine and Hygiene. She has graduated 12 PhDs, 8 MScs and many BSc (Hons) students. She has published 87 papers in reputed journals and co-authored 3 book chapters in books published by ASM and Humana Press. She has served as Ad Hoc reviewers for papers submitted to PLoSOne. After working for 25 years in the National University of Singapore (NUS), she is currently engaged as a Distinguished Professor by Sunway University. In her current role, she hopes to attract good graduate students and provide them with excellent supervision in research. She is often invited by reputable journals to contribute review papers and original research papers.

microbiology,virology.

Dr. Ahmed G. Hegazi is working in National Research Center, Dept. Zoonotic Diseases and Professor of Microbiology & Immunology. He won Second Best Research Paper award From International Congress of propolis, Bones Aires, Argentina in 2000 and awarded of Ghazi Wad Allah Salon Prize in 2008. Organized training courses on Immunology, National Research Center in 1987-2002. He also awarded 2 Bronze medals from The International Innovation Fair of the Middle East on 23th - 26th October, 2007, Kuwait.

Microbiology,Immunology.

Associate Professor Dr. Gamil G. S. Zeedan obtained Ph.D. Virology ,Cairo University Egypt , MVSCs Virology, Cairo University. BVSCs , Cairo University . 2015 up to date Assistant Professor of Microbiology and Virology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia,2014 -2015 Associate Professor of Microbiology at National Research Center Ministry of High Education - Cairo Egypt -Cairo Egypt, .10-2013 Assistant Professor of Microbiology at Faculty of Medicine and Applied Medical Sciences –Northern Border University (NBU)- KSA) for 3acdemic years 2007- 2010,Assistant Researcher at National Research Center- Ministry of High Education - Cairo Egypt. He teaching the following curriculum,Medical Microbiology and Virology, Diagnostic Microbiology ,Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology.

Microbiology and Virology.